Is Willingness to Pay Higher for Cancer Prevention and Treatment? (English)
- New search for: Shah, K
- New search for: Shah, K
In:
Value in health
;
20
, 9
;
A451
;
2017
-
ISSN:
- Article (Journal) / Print
-
Title:Is Willingness to Pay Higher for Cancer Prevention and Treatment?
-
Contributors:Shah, K ( author )
-
Published in:Value in health ; 20, 9 ; A451
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2017-01-01
-
Size:A451
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610.28
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610.28 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 20, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A399
-
The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In ScotlandHaghpanahan, H / Boyd, KA / Mackay, DF / Mcintosh, E / Pell, J / Haw, S et al. | 2017
- A400
-
Playing in the Same Pond - The Impact of Brexit on Clinical Trials and AccessWang, GD / Macaulay, R et al. | 2017
- A401
-
Multivariate Network Meta-Analysis of Survival Function ParametersCope, S / Chan, K / Jansen, JP et al. | 2017
- A402
-
Predictive Analysis for Identifying Patient Characteristics Associated with Primary Medication Nonadherence for Lipid Lowering TherapiesHill, JW / Rane, PB / Hines, DM / Patel, J / Harrison, DJ / Wade, RL et al. | 2017
- A403
-
Innovative Pricing and Reimbursement Schemes – The What, Why, Which, and HowMacaulay, R / Hettle, R et al. | 2017
- A404
-
A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular DiseaseKohli-Lynch, CN / Boyd, K / Briggs, A / Delles, C et al. | 2017
- A405
-
Cost-Effectiveness of Diagnosis: from Tests to Long-Term Outcomes and CostsFaria, R / Soares, M / Spackman, E / Ahmed, H / Brown, L / Kaplan, RS / Emberton, M / Sculpher, M et al. | 2017
- A406
-
Does Using Factor Analysis to Select Covariates in Mapping Algorithms Improve Predictive Accuracy? A Case of Mapping the Core 23-Item Women's Health Questionnaire Onto the EQ-5D-5L and SF-6DKaambwa, B / de Lacey, S / Smith, C / Ratcliffe, J et al. | 2017
- A407
-
Calibration Approach Impact on Health and Cost-Effectiveness Outcomes in a Decision Analytic FrameworkMoriña, D / Díaz, M et al. | 2017
- A408
-
Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology IndicationsSoikkeli, F / Hashim, M / Mueller, S / Groth, A / Wilke, T / Heeg, B et al. | 2017
- A409
-
Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?Allen, G / Hall, A / Hanman, K / Le Fevre, R / Griffiths, A et al. | 2017
- A410
-
Estimating The Public Economic Impact Of Different Hepatitis C Healthcare Policies In The NetherlandsConnolly, M / Kotsopoulos, N et al. | 2017
- A411
-
Detrimental Impact of Toxicity on Quality of Life In Hepatocellular Carcinoma Patients Treated with Lenvatinibor SorafenibHudgens, S / Misurski, D / Meier, G et al. | 2017
- A412
-
Comparative Effectiveness Of Novel Treatments For Advanced Melanoma: A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety OutcomesFranken, M / Leeneman, B / Gheorghe, M / Buyukkaramikli, N / Gerrits, J / van der Helm, I / Uyl-De Groot, C / Versteegh, M / Haanen, J / van Baal, P et al. | 2017
- A413
-
Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGSDavies, J / Gray, P / Hickey, DA et al. | 2017
- A414
-
Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma PatientsSabatelli, L / Jamotte, A / Giannopoulou, C et al. | 2017
- A415
-
Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma: Crossover Versus No CrossoverTremblay, G / Garib, SA / Meir, G / McElroy, HJ / Guo, M et al. | 2017
- A416
-
Clinical Comparison of First-Line Platin Chemotherapy Regimens In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Using German Registry DataHaas, JS / Meise, D / Ogbonnaya, A / Braun, S / Eaddy, M / Daeßler, K / Sandner, R / Binninger, A / Jaenicke, M / Chiabudini, M et al. | 2017
- A417
-
Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii MelanomaMa, J / Kuzman, J / Ray, A / Khong, B / Lawson, BO / Xuan, S / Khong, HT et al. | 2017
- A418
-
Estimating The Number of Relapsed And Refractory Indolent Lymphoma Patients Across Europe, Who Are Expected To Initiate A New Line of Therapy (LOT)Ellis, H / Neves, C / Chapman, A / Jeyakumaran, D et al. | 2017
- A419
-
A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian CancerBedel, DJ / Ricci, V / Sarri, G / Lavaud, V et al. | 2017
- A420
-
Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer PatientsKulakova, M / Hashim, M / Pfeiffer, B / Postma, M / Heeg, B et al. | 2017
- A421
-
Survival Rates In Primary Hepatic Carcinoma Patients With Cirrhosis In South Korea: A Retrospective Analysis of 68, 328 Patients In The National Cancer RegistryYang, J / Choi, I / Suh, J / Tchoe, H / Shin, S et al. | 2017
- A422
-
Budget Impact of Ribociclib Plus Letrozole For The Treatment of Post-Menopausal Women With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2- Negative (HER2-) Advanced or Metastatic Breast Cancer From A US Private Third-Party Payer PerspectiveMistry, R / Suri, G / Young, KC / Hettle, R / May, JR / Brixner, D / Oderda, G / Biskupiak, J / Tang, D / Bhattacharyya, D et al. | 2017
- A423
-
Budget Impact of Atezolizumab for The Treatment of 2nd Line Non-Small Cell Lung Cancer (NSCLC) After Failure with Platinum Containing Chemotherapy in GreeceKourkoulas, N / Kyriopoulos, D / Athanasakis, K et al. | 2017
- A424
-
Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in TaiwanTang, C / Jiang, J / You, S / Cheng, W et al. | 2017
- A425
-
An Economic Evaluation Model for Follicular Lymphoma (FL): Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational DataWang, H / Aas, E / Smith, A / Roman, E / Crouch, S / Burton, C / Patmore, R et al. | 2017
- A426
-
Cost Impact of Protocol Compliance for Cancer Treatment Plans in The Private Healthcare EnvironmentKotzé, L et al. | 2017
- A427
-
Estimation of The Cost of Metastatic Melanoma in France Using Melbase DataKandel, M / Allayous, C / Dalle, S / Dalac, S / Saiag, P / Lacour, J / Descamps, V / Maubec, E / Lesimple, T / Stoebner, P et al. | 2017
- A428
-
Retrospective Analysis of Hospital Episode Statistics Data To Estimate The Economic Burden of Vaginal and Vulval Cancer in England (2009-2015)Chatterjee, A / Matthews, I / Stephens, S et al. | 2017
- A429
-
Resource use and Health-Care Costs of Chronic Lymphocytic Leukemia in SlovakiaOndrusova, M / Suchansky, M / Chudej, J / Psenkova, M et al. | 2017
- A430
-
Estimating The Drug Treatment Cost of Breast CancerBerghuis, AS / Koffijberg, H / Terstappen, LW / Sleijfer, S / IJzerman, MJ et al. | 2017
- A431
-
Cost Drivers of Lung Cancer Care: Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in EuropeSolem, CT / Penrod, JR / Lees, M / Macahilig, C / Luo, L / Verleger, K / Manley Daumont, M / Hertel, N et al. | 2017
- A432
-
Evaluating Adverse Events Costs in Cancer Patients in Lebanon From Two Payers PerspectiveEl Hashem, G / Becker, RV / Maskineh, C et al. | 2017
- A433
-
A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian CancerRetèl, VP / van Lieshout, C / Koole, S / Sikorska, K / Sonke, GS / van Driel, WJ / van Harten, WH et al. | 2017
- A434
-
Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based TherapyPignata, M / Le Lay, K / Luciani, L / McConnachie, C / Gordon, J / Chouaid, C / Roze, S et al. | 2017
- A435
-
An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-EffectivenessIncerti, D / Peneva, D / Shrestha, A / Ramaswamy, K / Smith, G / Stevens, W et al. | 2017
- A436
-
The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness AnalysisChen, S / Xuan, JW / Zhang, Y / Zhu, H / Luo, J / Tan, J / Liu, C / Qiu, M / Qu, S / Xiong, T et al. | 2017
- A437
-
A Literature Review of Health Economic Assessments, Health Care Resource Utilization (HCRU), and Health Related Quality-of-Life (HRQOL) in Patients with Gastric Cancer (GC)van Dalfsen, N / Contente, M / Gudala, K / Lee, D / Maglinte, G / Calvo, E et al. | 2017
- A438
-
Cost-Effectiveness of Ponatinib in The Treatment of Patients with Acute Lymphoblastic Leukemia with Philadelphia Chromosome Positive (PH+ ALL), Suitable for Allogeneic Stem Cell Transplant, in GreeceVellopoulou, K / Kourlaba, G / Giannoulia, P / Panagiotidis, P / Maniadakis, N et al. | 2017
- A439
-
The Choice of Effectiveness Criteria Affects Conclusions of Economic Evaluation of Health Care Innovations: Example Based on A Randomised Multicenter Trial Comparing Two Reduced Intensity Conditioning Regimen (FLU-BU-ATG) Vs. (FLU-TBI) For Matched Related Allogeneic Stem Cells TransplantationLe Corroller Soriano, A / Siani, C / Tabrizi, R / Bay, J / Boher, J / Faucher, C / Blaise, D et al. | 2017
- A440
-
Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in ChinaZhu, J / Ye, M / Fu, J / Wu, B / Chu, Y / Zhao, Y / Zhang, Y / Kuo, D / Su, B et al. | 2017
- A441
-
Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in CanadaQuon, P / Xiao, Y / Sorensen, S / Schultz, M / Tahami Monfared, AA et al. | 2017
- A442
-
Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare SystemLo Muto, R / Lenzi, M / Franzini, JM / Baggi, A / Bonetti, G / Hegenbarth, A et al. | 2017
- A443
-
Cost-Effectiveness of Sequential Treatment Containing Crizotinib for Non Small Cell Lung Cancer (ALK+) PatientsSabater Cabrera, E / Puente, J / Oyagüez, I / García-Campelo, R / Reguart, N / Rodriguez, D / Cobo, M / Soto, J / Moran, M et al. | 2017
- A444
-
Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in EuropeGaultney, JG / Ng, T / Uyl-de Groot, CA / Sonneveld, P / van Beers, EH / van Vliet, MH / Redekop, WK et al. | 2017
- A445
-
Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases: Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled TrialFusco, F / Wolstenholme, J / Gray, A / Chau, I / Dunham, L / Love, S / Roberts, A / Moschandreas, J / Virdee, P / Lewington, V et al. | 2017
- A446
-
Resource Use and Associated Costs of Managing Docetaxel-Related Neutropenic Sepsis in Patients with Advanced Non-Small Cell Lung Cancer in The UK Nhs: Reveal-NsPulfer, A / Hodgson, M / Patel, A / Purchase, J / Summerhayes, M / Newsom-Davis, T et al. | 2017
- A447
-
Comparison of Utility Values Implemented in Disease Models of Metastatic MelanomaGorry, C / Barry, M / McCullagh, L et al. | 2017
- A448
-
Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have "Full-Health" by EQ-5D-5LMurasawa, H / Matsuoka, Y / Tanaka, N / Takeda, Y / Uchikawa, S / Noto, S / Shimozuma, K et al. | 2017
- A449
-
Correlation Analysis Between Health State Values Derived From EQ-5D-5L And EQ-VAS in Japanese Breast Cancer PatientsIwatani, T / Noto, S / Tsugawa, K et al. | 2017
- A450
-
Preferences for Survival in Non-Small Cell Lung Cancer: Swinging for Home Runs or Base Hits?Hauber, AB / Penrod, JR / Gebben, D / Musallam, L et al. | 2017
- A451
-
Psychological Impact of Cancer: More Good than BadYao, G / Lai, J / Garcia, S / Yount, S / Cella, D et al. | 2017
- A452
-
Pro Instruments Used in Studies of Skin Cancer Since 1960Martin, A et al. | 2017
- A453
-
Health-Related Quality of Life after Major Lower Extremity Amputation Due to Musculoskeletal TumorsRepo, JP / Barner-Rasmussen, I / Roine, RP / Häkkinen, A / Blomqvist, C / Tukiainen, EJ et al. | 2017
- A454
-
Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)Vogel, A / Qin, S / Kudo, M / Hudgens, S / Yamashita, T / Yoon, J / Fartoux, L / Simon, K / Lopez, C / Sung, M et al. | 2017
- A455
-
Relation of QLQ-C30 and QLQ-CR29 Health Related Quality of Life Scales and Biochemical Indicators of Nutritional StatusGonzalez-Barba, F / Sat-Muñoz, D / Palomares-Chacon, U / Martinez-Herrera, B / Hernandez-Covarrubias, O / Balderas-Peña, L et al. | 2017
- A456
-
Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell CarcinomaCella, D / Motzer, R / Rini, BI / Cappelleri, JC / Ramaswamy, K / Arondekar, B / Bushmakin, AG et al. | 2017
- A457
-
International HTA Experience With Targeted Therapy Approvals For Lung CancerMaraiki, F / Byrnes, J / Tuffaha, H / Hider, M et al. | 2017
- A458
-
The Clinical Burden Of Bladder Cancer To The Brazilian SocietyRosim, MP / Sarti, FM / Riveros, B / Lucchetta, RC / Pedro, GO / Scatena, D / Okumura, LM / Nita, ME / Massaoka, MH / Volsi, EC et al. | 2017
- A459
-
Real-World Management And Outcomes Of Patients With Multiple Myeloma In Romania And PolandDytfeld, D / Coriu, D / Fink, L / Hemetsberger, M / Bjorklof, K / Toka, KS / Gatta, F / Niepel, D et al. | 2017
- A460
-
One Year Report Card For The Cancer Drugs Fund Reforms – From Absurdity To Irrelevance?Walsh, SC / Dave, K / Tsang, R / Macaulay, R et al. | 2017
- A461
-
German Amnog Benefit Assessment: The Type Of Appropriate Comparator Makes The DifferenceTemplin, C / Billig, S / Damen, D / Kulp, W et al. | 2017
- A462
-
Real-World Evaluation Of Physician Attitudes Towards The Prescription Of Androgen Deprivation Therapy For Patients With Prostate CancerWittrup-Jensen, KU / Hallworth, P / Alvarez, ML / Rider, A et al. | 2017
- A463
-
Changes In Treatment Patterns Of Tyrosine Kinase Inhibitors Among Non-Small Cell Lung Cancer Patients Under The National Health Insurance In TaiwanChang, J / Wang, C / Lin, F et al. | 2017
- A464
-
Systematic Review Of Pivotal Studies Of Oncology Drugs Authorized In Italy Since 2013: Correlation Between Studies' Main Characteristics And Time To PatientPrada, M / Sansone, C / Mantovani, M et al. | 2017
- A465
-
Disease Burden During The "Watchful Waiting" Period In Women With Recurrent Ovarian Cancer In GermanyHarrow, B / Konieczny, A / Pignot, M / Wilk, A / Bala, M et al. | 2017
- A466
-
Do Countries With Similar GDPS And Health Expenditures Reimburse The Same Cancer Drugs?McKendrick, J / Malcolm, B / Sheahan, K / Katsoulis, IA / Song, X / van Loon, J et al. | 2017
- A467
-
Managed Entry Agreements (MEA): Analysis Of The Current Situation In Middle East And North AfricaDokuyucu, O / Gol, D / Arslan, B / Incioglu, F / Ozbek, O et al. | 2017
- A468
-
Emerging Markets Tiered Pricing: A Quantitative Assessment Of Local Affordability And Existing Price To PatientWalsh, K / Jaffar, S / Thakerar, S et al. | 2017
- A469
-
A Review of The Approaches Used To Model Subsequent Treatments In Nice Economic Evaluations: Examples Within Multiple Myeloma And Renal Cell CarcinomaLee, D / Gudala, K / Morgan, P et al. | 2017
- A470
-
PROS In Oncology HTA Decisions, Do They Matter?Hintzen, CL / Lie, X / van Engen, A / New, MJ et al. | 2017
- A471
-
Guideline Adherence In Docetaxel Treatment Of Castration Resistant Prostate Cancer (CRPC) Patients In A Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) In The NetherlandsWestgeest, H / Kuppen, M / Van den Eertwegh, A / Gerritsen, W / Uyl-de Groot, C et al. | 2017
- A472
-
Trucs And CAR-TS - The Emergence Of Io Cell TherapiesWang, GD / Macaulay, R et al. | 2017
- A473
-
Real World Treatment Patterns And Resource Use For Advanced Non-Small Cell Lung Cancer In Brazilian Private InstitutionsBaldotto, CS / Mascarenhas, ES / Laloni, MT / Wiermann, EG / Kussumoto, C / Azevedo, CR / Julian, GS / Ed, Moreira / Aratangy, G / Tanaka, S et al. | 2017
- A474
-
Sodium-Glucose Co-Transporter-2 (Sglt-2) Inhibitors And The Risk of Fractures of The Upper or Lower Limb In Patients With Type 2 Diabetes: A Nested-Case Control StudySchmedt, N / Andersohn, F / Walker, J / Garbe, E et al. | 2017
- A475
-
Factors Associated With Sustained Smoking After Type 2 Diabetes Diagnosis In Korean MenKim, SM / Cho, MH / Choi, S / Kim, K / Chang, J / Koo, HY / Jun, JH / Lee, K / Park, SM et al. | 2017
- A476
-
Economic Burden of Cardiovascular Disease In Type 2 Diabetes: A Systematic ReviewAcs, A / Ludwig, C / Bereza, BG / Einarson, TR / Panton, UH et al. | 2017
- A477
-
One-Center Analysis of Cost Associated With Acromegaly Management In PolandElbaum, M et al. | 2017
- A478
-
Cost-Effectiveness of Switching To Insulin Degludec (IDEG) In Real-World Clinical Practice In ItalyHaldrup, S / Lapolla, A / Gundgaard, J / Wolden, ML et al. | 2017
- A479
-
Cost-Effectiveness of Community Pharmacists' Intervention For Patients With Type 2 Diabetes In Prevention of Diabetic RetinopathyShoji, M / Onda, M / Okada, H / Sakane, N / Nakayama, T et al. | 2017
- A480
-
Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In ItalyIannazzo, S / Mannucci, E / Reifsnider, O / Maggioni, AP et al. | 2017
- A481
-
Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)Ridyard, CH / Blair, J / Hughes, DA et al. | 2017
- A482
-
Using Diabetes Self-Management Questionnaire (DSMQ) to Assess Diabetes Self-Care Activities for Diabetes Patients in King Fahad University Hospital - Saudi ArabiaAl shayban, DM et al. | 2017
- A483
-
Quality of Life Among Patients with Diabetes Mellitus at King Abdulaziz University Hospital in Saudi ArabiaHamdi, E / Baghlaf, N / Almasri, D / Noor, A / Bagalagel, A et al. | 2017
- A484
-
Economic and Humanistic Burden of Illness Amongst Diabetes Patients Experiencing Treatment InertiaLeith, A / Kelly, M / Ellams, A / Piercy, J et al. | 2017
- A485
-
Costs of Clinical Events in Diabetes Type 2 Patients in the Netherlands: A Systematic Reviewvan Schoonhoven, A / de Vries, M / Gout-Zwart, J / Vemer, P / van Boven, J / Dvortsin, E / Postma, MJ et al. | 2017
- A486
-
Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes: A Health Economic Analysis in the UkPollock, RF / Valentine, WJ et al. | 2017
- A487
-
Patient Characteristics of Premix Insulin Users in China: An Analysis of Electronic Medical Record DataHan, S / Wang, K / Hou, J / Wang, J / Wu, EQ et al. | 2017
- A488
-
Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic HyperplasiaAvxentyev, N / Frolov, M et al. | 2017
- A489
-
Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH)Bowditch, S / McCrea, C / Arbe, E / Nazir, J et al. | 2017
- A490
-
A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in IranPeikanpour, M / Sharif, Z / Foroughi Moghadam, MJ et al. | 2017
- A491
-
Quality of Life in Patients with Kidney Transplantation in Czech RepublicBielik, J / Dingova, M / Melus, V / Jurdikova, K et al. | 2017
- A492
-
Assessment of Knowledge, Attitude and Common Barriers Towards Reporting Adverse Drug Reactions by Public in MalaysiaArief, M / Bheemavarapu, H / Khan, A / Ahmad, A / Khan, MU / Saleem, F / Hassali, MA et al. | 2017
- A493
-
The Occurrence and Territorial Distribution of Acute Myocardial Infarctions in HungaryNémeth, N / Elmer, D / Pónusz, R / Bánkyné Perjés, B / Kerner, Á / Boncz, I / Endrei, D et al. | 2017
- A494
-
Microbiological, Chemical Analysis and Comparison of Public Bath Waters in Baranya County Between 2010-2016Kapitány, R / Galambos, A / Danku, N / Boncz, I / Pusztafalvi, H et al. | 2017
- A495
-
Effects of Low Salt Diet on Gene Expression in Dog HeartRen, X / Zhang, R et al. | 2017
- A496
-
Comparing The Healthcare Cost Utilization Of Paediatric Patients With Haemophilia A With And Without Inhibitors Treated At Instituto De Seguridad Social Del Estado De Mexico Y MunicipiosLopez Facundo, A / Mercado Garcia, J / Rodriguez Castillejos, C / Fonseca Zarco, A / Garcia Uranga, J et al. | 2017
- A497
-
Direct Medical Costs In The Year Of Mortality For Patients With Diabetes: A Population-Based Patient-Level AnalysisWong, CK / Jiao, F / Tang, EH / Fung, CS / Lam, CL et al. | 2017
- A498
-
Resource Utilisation And Related Health Care Costs Among Patients With Multiple Myeloma With ≥ 2 Prior Lines Of Treatment In Finland: Evaluation Based On Finnish Real World Data From Auria BiobankKosunen, M / Kurki, S / Snicker, K / Wiik, E et al. | 2017
- A499
-
The UK's Binge Drinking Culture: Losing More Than Just Our Dignity?Martin, RL et al. | 2017
- A500
-
Heart Failure Management: Impact Of A New Health-Care Organisation On Readmissions And CostsBourel, G / Duteil, E / Mahieu, N / Roubille, F / Mercier, G et al. | 2017
- A501
-
One Size Does Not Fit All: What Are The Appropriate Screening Intervals For People At Risk Of Diabetic RetinopathyWinfield, TG / Thomas, R / Luzio, S / Anderson, P / Dunstan, F / Peter, R / Owens, D et al. | 2017
- A502
-
Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC): Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And RegorafenibVenkatachalam, M / Stenehjem, D / Parikh, ND / Singh, P / Marett, B / Sill, B / Wisniewski, T / Shukla, P / Korytowsky, B / Siddiqui, MK et al. | 2017
- A503
-
Does The Study Population And The Use Of Proxy Respondent Have An Effect On The Latent Quality Of Life Constructs Measured By The CHU9D And The Pedsqltm 4.0? An Exploratory Factor AnalysisMpundu-Kaambwa, C / Chen, G / Huynh, E / Russo, R / Ratcliffe, J et al. | 2017
- A504
-
The Post-Traumatic Stress Disorder And Medication Adherence Encountered At Patients With Rheumatoid ArthritisSubtirelu, M / Turcu-Stiolica, A / Vreju, F / Turcu-Stiolica, RA / Neamtu, J et al. | 2017
- A505
-
Value Based Healthcare In Orthopaedic Surgery: An Evaluation Based On The Economist Intelligence Unit Global Assessment FrameworkTavare, A / Boshnakova, A / Pannelay, A / Jayakumar, P et al. | 2017
- A506
-
Tools For Improving Efficiency In Clinical Management And Safety Of Hypertensive Patients. Efigie-hta ProjectHidalgo, A / Orozco-Beltrán, D / Górriz, JL / Ferrer, D / Sabaté, N / Martell, N / Muñiz, O / Galgo, A et al. | 2017
- A507
-
Effect Of Pharmaceutical Care Intervention On Well-Being Index Of Type 2 Diabetes Outpatients In A Tertiary Hospital In Southeast NigeriaOgbonna, BO / Oparah, A et al. | 2017
- A508
-
Pre-Hospital Pain Relief Treatment In Patients With Musculoskeletal Injuries Experiencing Moderate To Severe Pain In Medical EmergenciesXia, A / Nokela, M / Liebmeier, M / Szende, A / Colman, S et al. | 2017
- A509
-
Estimated Clinical Impact Of Two Oncologic Drug ShortagesDe Weerdt, E / Simoens, S / Casteels, M / Huys, I et al. | 2017
- A510
-
Unmet Healthcare Needs Due To Financial Reasons In Times Of AusterityZavras, D / Naoum, P / Athanasakis, K / Kyriopoulos, J / Pavi, E et al. | 2017
- A511
-
Cost Of Hospitalizations For Nontuberculous Mycobacterial Pulmonary Disease In France In 2014: A PMSI Database AnalysisLafuma, A / Emery, C / Bureau, I / Chiron, R / Stahl, J et al. | 2017
- A512
-
Use Of Healthcare Resources And Associated Costs Of Idiopathic Pulmonary Fibrosis In Spain: A Real-Life StudySicras-Mainar, A / Somiedo Gutiérrez, Md / Navarro-Artieda, R / Arroyo Rivera, MI et al. | 2017
- A513
-
Health Service Implications Of The Implementation Of An Early Discharge Strategy For Patients Admitted In Infectious Diseases Departments In Southern EuropeRestelli, U / Bonfanti, M / Rizzardini, G / Moreno Guillén, S / Grau Cerrato, S / Metallidis, S / Pacelli, V / Soro, M / Croce, D et al. | 2017
- A514
-
Investing In Skilled Specialists To Grow Hospital Infrastructure And Improve QualityPadula, WV / Nagarajan, M / Davidson, PM / Pronovost, PJ et al. | 2017
- A515
-
Public Hospital Supply Chain: Current View And Critical Issues In ItalyTriulzi, I / Antonel, A / Rossi, E / Turchetti, G et al. | 2017
- A516
-
Emergency Department Use Among Autosomal Dominant Polycystic Kidney Disease Patients In The USClark, LA / Patel, R / Blanchette, CM / Noone, JM / Zenarosa, GL / Howden, R et al. | 2017
- A517
-
Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016Isaza, D / Acuña, L / Bryón, A / Gutiérrez, B / Sanchez, P / Soler, L / Merchan, A / Ruiz, A / Aschner, P et al. | 2017
- A518
-
Impact Of Lifestyle Education And Pharmacist Intervention Of Drug-Related Problems On Elders At High Risk Of Having DementiaLee, VW / Tang, VL / Ti, M / Fong, F / Ngai, L / Lam, A et al. | 2017
- A519
-
A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And SpainGizzo, S / Ferrando, M / Lispi, M / Alvarez Nieto, J / Bilger, W / Ripellino, C / Cataldo, N / Eheberg, D / Bühler, K et al. | 2017
- A520
-
Cost-Comparison Between the Etonogestrel Implant and the Medroxyprogesterone Acetate Injectable: Number of Unintended Pregnancies and Financial ImpactPraet, C / Taymor, E / Mayes, A et al. | 2017
- A521
-
Testosterone Replacement therapy As An Anti-Ageing Treatment for Men: A Literature Review and Economic EvaluationHopkins, OR / Chan, SL et al. | 2017
- A522
-
Factors Associated with Medication Adherence in Korean Postmenopausal Osteoporosis(PMO): Results from PMO Outcomes Research(OR)Min, Y / Byun, D / Moon, S / Kim, T / Kim, HJ / Kim, Y et al. | 2017
- A523
-
Medication Related Quality of Life Among Ethiopian Elderly Patients with Polypharmacy: The Case of North Gondar ZoneTegegn, HG / Erku, dA / Sebsibe, G / Gizaw, B / Seifu, D / Tigabe, M / Belachew, sA / Ayele, AA et al. | 2017
- A524
-
Effects of Propofol Versus Other General Anesthesia in Children Younger Than 3 Years of Age: A Systematic Review and Meta-AnalysisHong, H / Choi, Y / Kim, S / Jang, M / Lee, J / Kim, H / Hahn, S et al. | 2017
- A525
-
Value and Impact of Incorporating Uncertainty into Opinion Based Research: Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)Hariharan, D / Rittenhouse, B et al. | 2017
- A526
-
Access and Secondary Use of Data Collected In An Electronic Medical Chart: Results Of The Real World Roswitch StudyDarloy, J / Segaud, N / Baudens, G / Eschard, J / Goeb, V / Salmon, J / Chopin, C / Deprez, X / Houvenagel, E / Idier, I et al. | 2017
- A527
-
The Study on Mechanism of Nf-Κb Signal Molecule In Kashin-Beck DiseaseXiong, YM / Wu, RP / Yang, XL / Zou, XZ / Zhang, RQ / Shi, ZY / Ma, MJ / Pan, MM et al. | 2017
- A528
-
Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in FinlandPurmonen, T / Wahlman, H et al. | 2017
- A529
-
Estimation of the Additional Budget Saving Potential Due to the Rapid Adoption of An Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in SpainPsachoulia, E / Chouman, S et al. | 2017
- A530
-
Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total HIP Replacement: Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 120, 000 PatientsBlin, P / Samama, C / Sautet, A / Mismetti, P / Benichou, J / Lignot-Maleyran, S / Lamarque, S / Lorrain, S / Lassalle, R / Gaudin, A et al. | 2017
- A531
-
The Impact of Rheumatoid Arthritis (RA) on a Patient's Ability to Stay in Work and Level of Pain ExperiencedCapron, J / De Leonardis, F / Fakhouri, W / Burke, T / Rose, A / Jacob, I et al. | 2017
- A532
-
A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer PerspectiveGunda, P / Nikoglou, E / Jugl, SM / Murphy, A et al. | 2017
- A533
-
Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian PerspectiveChiva-Razavi, S / Jain, M / Graham, CN / Miles, L / Nikoglou, E / Gunda, P et al. | 2017
- A534
-
Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from an Argentinian PerspectiveBarbeau, M / Bianculli, PM / Nikoglou, E / Gunda, P / Jugl, SM / MacPherson, A et al. | 2017
- A535
-
Cost-Minimization Analyses of Biological Therapies in the Treatment of Rheumatoid Arthritis from the Egyptian Healthcare System PerspectiveMetry, AB / Elsisi, GH / ElShafei, ZA et al. | 2017
- A536
-
Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in ItalyDegli Esposti, L / Perrone, V / Sangiorgi, D / Alessandrini, D / Buda, S / Cantini, F / Toma, C / De Solda, F / Mazzini, E / Nappi, C et al. | 2017
- A537
-
Pooled Real World Databases Analysis of Patient's Reported Outcomes In Rheumatoid Arthritis PatientsSaraux, A / Cantagrel, A / Combe, B / Flipo, R / Idier, I / Guillier, R / Pau, D / Tebib, J et al. | 2017
- A538
-
Real-World Health-Related Quality of Life Eq-5d-5l Outcomes In Ankylosing Spondylitis (AS): Analysis of Data From The Uk British Society For Rheumatology Register In Ankylosing Spondylitis (BSRBR-AS) StudyNeilson, AR / Jones, G / Macfarlane, G / Pathan, E / McNamee, P et al. | 2017
- A539
-
Management Of Chronic Gout – A Delphi (CONSENSUS) Consultation Of UK-Based Clinical ExpertsBaxter, G / Johannes, EJ / Lee, J / Aldhouse, NV / Hepburn, AL et al. | 2017
- A540
-
Trends In Opioid Prescribing In Primary Care Patients With Knee Osteoarthritis: A Population Based Observational StudyTaqi, A / Otete, H / Knaggs, RD et al. | 2017
- A541
-
Number of Visits Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013Molics, B / Varga, V / Elmer, D / Ferenczi, Z / Szőts, B / Kerner, Á / Mazzag, K / Boncz, I et al. | 2017
- A542
-
Evaluation And Development of Habitual Posture And Posture Deemed Correct With Back School Program Among Primary School ChildrenSzilágyi, B / Makai, A / Ács, P / Boncz, I / Járomi, M et al. | 2017
- A543
-
The Economic Impact of Rheumatoid Arthritis on Patients' Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In GreeceSkroumpelos, A / Naoum, P / Athanasakis, K / Argyropoulos, E / Koutsogianni, A / Pavi, E / Kyriopoulos, J et al. | 2017
- A544
-
Comparing Efficacy of Guselkumab Versus Ustekinumab in Moderate to Severe Psoriasis Patients : An Adjusted Comparison Based on Voyage 1&2 and Navigate TrialsDiels, J / Thilakarathne, P / Schubert, A / McElligott, S et al. | 2017
- A545
-
Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease ModelThielen, F / Blommestein, HM / Oosten, L / Fibbe, W / Le Blanc, K / Locatelli, F / Sánchez-Guijo, F / Calkoen, F / Lankester, A / Algeri, M et al. | 2017
- A546
-
Drug Utilisation Study of Anti-Obesity Products Dispensed by Pharmacies in South AfricaTruter, I et al. | 2017
- A547
-
The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea: Findings from the NLBP ORKim, J / Hong, JT / Lee, C / Kim, K / Suk, K / Park, Y / Chang, B / Jun, DS / Kim, Y / Lee, J et al. | 2017
- A548
-
A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid SyndromeFust, K / Maschio, M / Pastor, L / Kohli, M / Weinstein, MC / Singh, S / Pritchard, M / Welin, S / Marteau, F / Gabriel, S et al. | 2017
- A549
-
Economic Evaluation of Subcutaneous Methotrexate For Long-Term Treatment of Moderate-To-Severe Psoriasis In The United KingdomBungey, G / Webb, N / Price, K / O'Leary, M et al. | 2017
- A550
-
Bypassing Agents Prophylaxis In Patients With Haemophilia And Inhibitors Undergoing Surgery: A Decision Analysis In SpainMareque, M / Mingot, ME / López, MF / Álvarez, MT / García, JP / Oyagüez, I et al. | 2017
- A551
-
Burden of Renal Transplant Among A Cohort of US Medicare Beneficiaries With Autosomal Dominant Polycystic Kidney DiseaseClark, LA / Patel, R / Blanchette, CM / Noone, JM / Zenarosa, GL / Howden, R et al. | 2017
- A552
-
A Systematic Literature Review On Quality Of Life And Economic Burden Of Psoriasis In The Asia-Pacific RegionChen, C / Ni, Q et al. | 2017
- A553
-
Costs Associated With Transthyretin Familial Amyloid Polyneuropathy ProgressionInês, M / Coelho, T / Conceicao, I / Borges, M / Carvalho, M / Costa, J et al. | 2017
- A554
-
Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And "No Intervention" In SwitzerlandNuijten, M / Marczewska, AM / Araujo Torres, K / Morton, M / Perugini, M et al. | 2017
- A555
-
Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic SyndromePriedane, E / Gagnon, J / Kumar, A et al. | 2017
- A556
-
Modelling For Rare Diseases: Case of Canakinumab In Periodic Fever Syndromes In FranceDuteil, E / Cawston, H / Pibouleau, L / Bregman, C / Mahieu, N / Cariou, C / Sion, M / Duco, J et al. | 2017
- A557
-
Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In SpainPeral, C / Cordido, F / Gimeno, V / Sanchez-Cenizo, L / Mir, N / Parrondo, J et al. | 2017
- A558
-
Compliance And Treatment Satisfaction With Biological Treatments For Systemic Juvenile Idiopathic Arthritis (SJIA)Shenoi, S / Horneff, G / Cidon, M / Ramanan, A / Kimura, Y / Quartier, P / Foeldvari, I / Zeft, A / Lomax, K / Gregson, J et al. | 2017
- A559
-
Societal Preferences For Funding Orphan Drugs In The UK: A Person Trade Off StudyBourke, SM / Plumpton, CO / Hughes, DA et al. | 2017
- A560
-
Health-Related Quality Of Life And Pharmacotherapy Costs Study For Patients With Rare Endocrine Diseases In Bulgaria – A Pilot StudyKamusheva, M / Zaharieva, S / Elenkova, A / Doneva, M / Dimitrova, M / Petrova, G et al. | 2017
- A561
-
Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver's PerspectiveShenoi, S / Horneff, G / Cidon, M / Ramanan, A / Kimura, Y / Quartier, P / Foeldvari, I / Zeft, A / Lomax, K / Gregson, J et al. | 2017
- A562
-
Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK: A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)Marshall, JD / Clayton, J et al. | 2017
- A563
-
Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In PolandSkora, K / Bochenek, T / Augustynska, J / Walczak, J et al. | 2017
- A564
-
How Should We Value Orphan Drugs? Suggestions From A Large Public Opinion SurveyKorchagina, D / Toumi, M / Aballea, S / Millier, A / Falissard, B et al. | 2017
- A565
-
Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany: A Real-World Preliminary AnalysisAlten, R / Neregård, P / Jones, HE / Meng, T / Curiale, C / Singh, E / Lucchese, L / Gossen, N / Bergman, GJ / Miglio, C et al. | 2017
- A566
-
Opioid Utilization And Cost Among Elderly And Non-Elderly Medicare Beneficiaries In The United States: A State-Level ComparisonTaira, D / Sumida, W et al. | 2017
- A567
-
Access To Medicines For Rare Diseases In Australia: The Current Climate For ReimbursementLee, CK / Proudfoot, EM / O'Leary, BA et al. | 2017
- A568
-
How Does The Scottish Medicines Consortium Assess The Value Of Orphan And Ultra-Orphan Drugs?Rothwell, B et al. | 2017
- A569
-
A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)Hann, G / Wordsworth, J / Ralston, S / Cork, D et al. | 2017
- A570
-
Fair Pricing Of Orphan Drugs In Relation To Additional Health Gains And Disease PrevalenceZelei, T / Csanadi, M et al. | 2017
- A571
-
Divergence of Evaluation of Orphan Drugs Between Regulators and Payers: Implications For Patient Access In US And EUIsmailoglu, I / Duttagupta, S et al. | 2017
- A572
-
Economic Analysis of Alk Related Companion Diagnosis Methods Before the Targeted Therapy for Non-Small Cell Lung CancerHe, J / Lu, X / Mao, Y / Hu, S et al. | 2017
- A573
-
Integrated 2 Screw Cepahlo-Medulary Device Reduces Device Related Post-Operative Complications and Pain After Intertrochanteric Fractures, Evidence From a Systematic Review and Meta-AnalysisNherera, L / Trueman, P / Horner, A / Watson, J et al. | 2017
- A574
-
Estimating the Comparative Accuracy of Diagnostic Tests: AN Example using Typhoid FeverArora, P / Thorlund, K / Brenner, DR / Andrews, JR et al. | 2017
- A575
-
Structured Education Program For Injection Technique - Budget Impact ModelLaroche, S / Hopley, C / Bourguignon, S / Strauss, K et al. | 2017
- A576
-
Clinical And Cost Impact of A Novel Non-Invasive Approach For The Treatment of Cervical Dysplasia From A US Payer PerspectiveEinstein, MH / Gavaghan, M / Infante, K et al. | 2017
- A577
-
ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer: Clinical And Budget ImpactPaolini, D / Tiseo, M / Dionisi, M / Demma, F / Furneri, G / Akkermans, M / Marchetti, A et al. | 2017
- A578
-
Multiplatform Tumor Profiling Delivers Value Based Health Care In Refractory Cancer PatientsRussell, KJ / Dean, A / Muckle, G / Hussain, T / Hernandez, A / Voss, A / Spetzler, D et al. | 2017
- A579
-
Comparison of U.S. Hospital Costs Between Transcatheter Aortic Valve Replacement (TAVR) And Surgical Aortic Valve Replacement (SAVR)Meduri, C / Chung, JK / Gaffney, JC / Henley, S / Williams, JM / Gada, H et al. | 2017
- A580
-
Micro Economic Analysis Of The COPD Exacerbations And Hospitalizations Burden On The Health Care System In BulgariaTachkov, K / Dimitrova, M / Mitov, K / Savova, A / Kamusheva, M / Dimitrov, JS et al. | 2017
- A581
-
Cost Consequence Analysis Of Different Gene Mutation Testing Modalities For Braf V600E Mutation In Advanced Non-Small Cell Lung Cancer Using A Decision Analytic ModelDalal, A / Zhou, Z / Tang, W / Ricculli, ML / Guerin, A / Sasane, M / Wu, K / Culver, K / Otterson, G / Pennell, N et al. | 2017
- A582
-
Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In IrelandMistry, R / Mbanya, Z / Liedgens, H et al. | 2017
- A583
-
Cost Effectiveness Of Urban Breast Cancer Screening Programme In ChinaSun, L / Yang, L et al. | 2017
- A584
-
Economic Evaluation Of Cerebral Oximetry Monitoring In Carotid Endarterectomy: The Emocar Randomized Controlled Trial (May 2011 - April 2016)Cabout, E / Kabeshova, A / Launois, R et al. | 2017
- A585
-
Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer PerspectivePodbielski, DW / Bilir, SP / Kowal, S / Bouchet, C / Morris, L / Gill, R / Ahmed, II et al. | 2017
- A586
-
Cost Effectiveness of Universal Neonatal Hearing Screening With Otoacoustic Emissions And/Or Automated Auditory Brainstem Response, For The Detection Of Bilateral Congenital Hearing Loss And Early Treatment, In Newborns Without Risk Factors, In ColombiaMedina Torres, YA / Diaz Rojas, JA / Gamboa Garay, OA et al. | 2017
- A587
-
Assessing The Cost-Effectiveness Of The Manchester Acute Coronary Syndrome (MACS) Decision-Aid: A Feasibility StudyThompson, AJ / Lecky, F / Body, R et al. | 2017
- A588
-
Cost-Effectiveness Analysis Of Stereotaxic Eeg (SEEG) As A Preoperative Diagnostic Procedure In Epilepsy SurgeryKovacs, S / Tóth, M / Boncz, I / Zemplenyi, A et al. | 2017
- A589
-
Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility InterventionsDragomir, A / Bonnevier, E / Kassouf, W / Aprikian, A / Palenius, E / Nazha, S et al. | 2017
- A590
-
Patient Insights In Copd Medication Adherence From Pharmacy DataSperber, CM / Samarasinghe, S / Collins, C / Lomax, G et al. | 2017
- A591
-
Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices: Insights From A Rheumatoid Arthritis Auto-Injector Preference StudyDomańska, B / Mountian, I / Vinconneau, G et al. | 2017
- A592
-
Public Perceptions, Attitudes And Willingness To Pay Towards A Medical Device For Detecting Foot Ulceration In People with DiabetesYang, F / Gannon, B / Weightman, A et al. | 2017
- A593
-
What Stroke Image Do We Want? European Clinician Survey On Acute Stroke Imaging And Revascularisation TreatmentPeultier, A / Redekop, WK / Dippel, D / Bereczki, D / SI Mohamed, S / Douek, PC / Severens, JL et al. | 2017
- A594
-
Reporting Clinical Outcomes In Tavi RegistriesKolominsky-Rabas, PL / Zhang, S et al. | 2017
- A595
-
Cost And Operational Efficiency Comparison Of An Integrated VS. A Multi-Step System For Extracorporeal Photopheresis In GermanyMaas, C / Kuchenbecker, U / Kontekakis, A et al. | 2017
- A596
-
Feasibility Assessment: The Impact of A Reduced Operating Room Footprint System On The Resources Required For Instrument Management In Deformity Surgery From An Italian Hospital PerspectiveTaylor, H / Zagra, A / Giudici, F / Scaramuzzo, L / Minoia, L / Archetti, M / Velleca, M / Paragò, V et al. | 2017
- A597
-
Estimate European Candidates For Bronchoscopic Lung Volume Reduction (BLVR) Technologies In The Treatment Of Severe EmphysemaBusca, R / Rott, C / Witt, C et al. | 2017
- A598
-
Retrospective Analysis of Patients Treated with Computer-Assisted External Ring Fixators: A Descriptive Analysis of Patient Demographics, Healthcare Untilization, And Costs In The U.SMenzie, AM / Sparks, CY / Holy, CE et al. | 2017
- A599
-
Comparison Of Catheter-Related Complications Between Manually-Prepared Saline Flush Syringes And Commercially Available Pre-Filled Saline Flush SyringesBal, V / Culiner, J / Nyarko, E et al. | 2017
- A600
-
Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling StudyMueller, M / Himmler, S / Basic, E / Hradetzky, E et al. | 2017
- A601
-
Gender Differences In Heart Failure: The Arno Italian ExperienceNica, M / Cinconze, E / Rossi, E / Colombo, D et al. | 2017
- A602
-
Blood Pressure Measuring Techniques, Examination of The Blood Pressure Values In Relation With The Operating Principle of The DeviceOláh, A / Radics, L / Müller, Á / Szabó, L / Szunomár, S / Boncz, I / Betlehem, J / Pakai, A et al. | 2017
- A603
-
Effects of Improved Detection And Treatment of Atrial Fibrillation On Burden of Disease Caused By Stroke In GermanyNolting, H / Deckenbach, B / Zich, K et al. | 2017
- A604
-
Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism: Systematic Review And Network Meta-AnalysisMartin Saborido, C / Jimenez, D / Muriel, A / Zamora, J / Morillo, R / Barrios, DD / Klok, E / Huisman, M / Yusen, R / Tapson, V et al. | 2017
- A605
-
Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United KingdomDanese, M / Kutikova, L / Catterick, D / Sorio-Vilela, F / Gleeson, M / Khunti, K / Seshasai, SR / Brownrigg, J / Ray, KK et al. | 2017
- A606
-
Budget Impact of Post-Stroke Dysphagia: Database Analyses of Hospital Discharges In France And SwitzerlandMuehlemann, N / de Léotoing, L / Jouaneton, B / Fernandes, J / Arnold, M / Kägi, G et al. | 2017
- A607
-
Analysis of Clinical And Economic Effectiveness of Statins For Secondary Prevention of Cardiovascular Disease In KazakhstanAvdeyev, A / Makalkina, L / Akanov, A / Kim, V / Baidullayeva, D / Toktybayeva, A / Dyusembayeva, N et al. | 2017
- A608
-
Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2: A French Nationwide Cohort Of 100, 000 Patients With Non-Valvular Atrial FibrillationBlin, P / de Pouvourville, G / Cottin, Y / Dureau-Pournin, C / Abouelfath, A / Lassalle, R / Bénichou, J / Droz-Perroteau, C / Mismetti, P / Moore, N et al. | 2017
- A609
-
Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In FranceBergot, E / de Léotoing, L / Bendjenana, H / Tournier, C / Vainchtock, A / Nachbaur, G / Humbert, M et al. | 2017
- A610
-
Economic Burden of Heart Failure In Asian CountriesKim, H / Kim, J / Chen, S / Numuang, K / Chong, YC / Suter, S / Ko, S et al. | 2017
- A611
-
Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk FactorsGagnon-Arpin, I / Verdejo Paris, J / Sutherland, G / Dobrescu, A / Villa, G / Habib, M / Alva, ME / Suarez, S et al. | 2017
- A612
-
Myocardial Revascularization: Comparative Cost Study In South America Health Care SystemTanaka, GK / Martins, LV / Greiffo, RH / Osternack, B / Gd, Matia / Tanaka, E et al. | 2017
- A613
-
Cost-Effectiveness Of Ivabradine In The Treatment Of Chronic Heart Failure From The Mexican PerspectiveConstanzo, AE / Rodriguez-Mendoza, MM / Sanchez-Trejo, K et al. | 2017
- A614
-
Use of Disease Risk Score In The Evaluation of Effectiveness For Purposes of HTAKamensky, V / Bulkova, V / Zakova, S et al. | 2017
- A615
-
The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation TreatmentKamensky, V / Bulkova, V / Bohacova, J et al. | 2017
- A616
-
Cost-Effectiveness Analysis of Standard Therapy with Phosphocreatine VS Standard Therapy In Perioperative Management of Cardiac Surgery Patients With Extracorporeal Circulation, With Ischemic Heart Disease or With Chronic Heart InsufficiencyYagudina, R / Kulikov, A / Skripnik, A et al. | 2017
- A617
-
The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In KoreaLee, J / Ko, S et al. | 2017
- A618
-
Hearth Failure (HF) In Apulia Region - Italy (Local Health Unit Barletta – Andria – Trani): Analysis Of The Therapeutic Pathways And Related Healthcare ConsumptionPerrone, V / Sangiorgi, D / Degli Esposti, L / Modugno, G / D' Ambrosio, G / Diaferia, G / Delvecchio, B / Dell'Orco, ML / Masullo, M / Ancona, D et al. | 2017
- A619
-
Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians' Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American College of Cardiology/American Heart Association (ACC/AHA): Results from Korea Cristar StudyChae, I / Kim, B / Lee, J / Oh, J / Cho, B / Shin, E / Nah, D / Lee, S / Bae, J / Park, J et al. | 2017
- A620
-
Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy: A Systematic ReviewForbes, CA / Deshpande, S / Sorio-Vilela, F / Kutikova, L / Duffy, S / Gouni-Berthold, I / Hagström, E et al. | 2017
- A621
-
The Impact of Beliefs Towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients in Hong KongLee, VW / Fung, K / Cheung, V / Yan, BP et al. | 2017
- A622
-
Reduction of LDL-C Levels is Most Important - Patient Preferences for Drug Treatment Adjunct to LDL-C Apheresis in Severe HypercholesterolemiaMühlbacher, AC / Sadler, A / Dippel, F / Juhnke, C et al. | 2017
- A623
-
Factors Associated with Quality of Life(QOL) In Peripheral Arterial Disease(PAD) Patients in Korea: Results from Pad Outcomes Research(OR)Choi, D / Rha, S / Choi, S / Kim, HJ / Kim, Y et al. | 2017
- A624
-
Intermediate Evaluation of Vivoptim: The Mgen (French Insurer) Prevention Program for Cardiovascular RisksBlachier, M / Vimont, A / Ballouk, S / Le Lann, A / Femery, V et al. | 2017
- A625
-
Poor Outcomes Associated with Antithrombotic Potential Undertreatment in Patients with Atrial Fibrillation: A Retrospective Cohort StudyGebreyohannes, EA / Tegegn, HG / Bhagavathula, AS et al. | 2017
- A626
-
Utilization of Lipid-Lowering Drugs in Slovakia: Comparison of Data from Different SourcesHaramiova, Z / Stasko, M / Cernicka, D / Tesar, T et al. | 2017
- A627
-
Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia:A Hospital-Based Observational StudyAbegaz, TM / Tefera, YG / Abebe, TB et al. | 2017
- A628
-
Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease: A Population-Based Study in South KoreaSuh, HS / Kim, S / Kim, H / Kim, E / Han, S / Rane, PP / Fox, KM / Zhao, Z / Qian, Y et al. | 2017
- A629
-
Patient Care Pathway for Post-Stroke Spasticity and Bont Management in French Hospitals Through the Prism of PMSI DataJosseran, L / Baptiste, C / Bensmail, D / Karam, P et al. | 2017
- A630
-
Real-World Treatment Patterns Among Patients Initiating on Statins in EnglandLambrelli, D / Merinopoulou, E / Donaldson, R / Mardekian, J / Hlavacek, P / Tarasenko, L / Masseria, C / Hobbs, FD et al. | 2017
- A631
-
Risk Of Complications With Minimally Invasive Surgery In Liver ResectionWei, D / Gutierrez, M / Goldstein, LJ et al. | 2017
- A632
-
A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium DifficileLeinwand, B et al. | 2017
- A633
-
Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)Tyson, C / Shafran, I / Hilal, R / Chalasani, R / Good, L / Taxman, T / Maheshwari, S / Silver, HS / Glamour, TS / Wallis, BJ et al. | 2017
- A634
-
Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)Walter, E / Lazic-Peric, A / Schalle, K et al. | 2017
- A635
-
Cost-Effectiveness Analysis of Ulinastatin for Patients Undergoing Hepatectomy: A Discrete Event Simulation ModelLin, Z / Zhou, J / Yang, Q / Xing, R / Li, M / Yu, Q / Xuan, JW et al. | 2017
- A636
-
Healthcare Resource Utilization in Patients with Moderate to Severe Ulcerative Colitis: A Brazilian Real World StudyDecimoni, TC / Sztajnbok, S / Feitosa, MR / Parra, RS et al. | 2017
- A637
-
Interrogating Social Media Sources to Gain Insight on Opioid-Induced Constipation Symptoms as Reported By PatientsBrewer, S / Kennedy-Martin, T et al. | 2017
- A638
-
The Value Of Real-World Evidence To Support Value-Based Decision-Making: Examples For Vedolizumab In Inflammatory Bowel DiseaseDemuth, D / Bashford-Bovens, SM / Crutwell, JR / Papageorgakopoulou, C / Minda, K / Khalid, JM et al. | 2017
- A639
-
Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and ProgressionDevillier, P / Molimard, M / Demoly, P / Ansolabehere, X / Bardoulat, I / Coulombel, N / Maurel, F / Le Jeunne, P et al. | 2017
- A640
-
Estimating The Proportion of Patients Diagnosed with Allergic Rhinitis, at Risk of Developing AsthmaRomano, M / Burton, CM / Domdey, A / Radford, PD / Dungarwalla, MH / Boxall, NS et al. | 2017
- A641
-
Budget-Impact of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In GreeceSolakidi, A / Tzanetakos, C / Bilir, SP / Beaudet, A / Zervoudaki, A / Lamprou, C / Maniadakis, N et al. | 2017
- A642
-
Economic Evaluation of Multi-Drug Resistant Tuberculosis In Ghana: Patient Level Direct Cost Analysis 2013 - 2016Davies-Teye, B / Dziedzom, A / Vanotoo, L / Eleeza, J / Fa, Bonsu et al. | 2017
- A643
-
Evidence Map of Costs Studies In Cystic Fibrosis Since 2000Martin, A et al. | 2017
- A644
-
Cost-Benefit Analysis of A Smoking Cessation Program Funded By The Spanish National System In Pre-Operative PatientsJiménez, CA / Martín, V / Rejas, J et al. | 2017
- A645
-
Assessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary DataTrieste, L / Silvestri, M / Tosca, MA / Turchetti, G et al. | 2017
- A646
-
Cost –Utility Analysis of Two Budesonide Inhalers For Treatment of Asthma In Children In Russian FederationMakarova, E / Yagudina, R / Kulikov, A et al. | 2017
- A647
-
Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool TaiAyele, AA / Tegegn, HG et al. | 2017
- A648
-
Social Burden of CopdTachkov, K / Kamusheva, M / Pencheva, V / Mitov, K et al. | 2017